Published in Cell Cycle on February 01, 2012
The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity (2008) 4.44
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod (2003) 2.09
In vitro cell migration and invasion assays. Mutat Res (2012) 1.91
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet (2008) 1.85
The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat Res (2008) 1.45
The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: mercury and lead. Mutat Res (2010) 1.36
Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene (2002) 1.35
The mTOR pathway and its role in human genetic diseases. Mutat Res (2008) 1.33
Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments. Hum Mutat (2009) 1.20
Hedgehog signaling regulates segment formation in the annelid Platynereis. Science (2010) 1.12
Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet (2010) 1.11
Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol (2004) 1.11
Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle. Hum Mol Genet (2009) 1.11
Circadian and circalunar clock interactions in a marine annelid. Cell Rep (2013) 1.08
The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr (2012) 1.07
Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene (2003) 1.06
Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood (2011) 1.06
Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle. Nat Protoc (2013) 1.05
p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet (2007) 1.02
The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27. Mutat Res (2006) 1.02
Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med (2005) 1.01
Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat Protoc (2010) 1.00
Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev (2007) 0.95
Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget (2011) 0.92
Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. J Biol Chem (2004) 0.89
The first trimester human trophoblast cell line ACH-3P: a novel tool to study autocrine/paracrine regulatory loops of human trophoblast subpopulations--TNF-alpha stimulates MMP15 expression. BMC Dev Biol (2007) 0.89
Short 42 degrees C heat shock induces phosphorylation and degradation of Cdc25A which depends on p38MAPK, Chk2 and 14.3.3. Hum Mol Genet (2009) 0.89
Detection of cytoplasmic and nuclear functions of mTOR by fractionation. Methods Mol Biol (2012) 0.89
Induction of mesenchymal/epithelial marker expression in human amniotic fluid stem cells. Reprod Biomed Online (2009) 0.88
Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation. Hum Mol Genet (2011) 0.88
p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin. J Immunol (2013) 0.87
Immune responses of macrophages and dendritic cells regulated by mTOR signalling. Biochem Soc Trans (2013) 0.85
FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Am J Pathol (2004) 0.85
Tuberin--a new molecular target in Alzheimer's disease? Neurochem Res (2005) 0.85
mTOR protein localization is cell cycle-regulated. Cell Cycle (2011) 0.84
Differentiation of neuroblastoma cell line N1E-115 involves several signaling cascades. Neurochem Res (2005) 0.83
The decision on the "optimal" human pluripotent stem cell. Stem Cells Transl Med (2014) 0.83
Amniotic fluid stem cells and fetal cell microchimerism. Trends Mol Med (2013) 0.82
Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25. J Proteome Res (2009) 0.82
Expression of mTOR pathway proteins in human amniotic fluid stem cells. Int J Mol Med (2009) 0.81
New insights into the role of the tuberous sclerosis genes in leukemia. Leuk Res (2009) 0.81
Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy. Stem Cell Rev (2012) 0.81
Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics (2004) 0.81
[The first preimplantation diagnosis in Austria]. Wien Klin Wochenschr (2005) 0.81
Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int (2012) 0.80
Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases. Eur J Clin Invest (2011) 0.80
Bach2 is involved in neuronal differentiation of N1E-115 neuroblastoma cells. Exp Cell Res (2006) 0.80
Pedigree analysis and descriptive investigation of three classic phenotypes associated with Holt-Oram syndrome. J Reprod Med (2003) 0.80
A novel missense NDP mutation [p.(Cys93Arg)] with a manifesting carrier in an austrian family with Norrie disease. Audiol Neurootol (2014) 0.79
Proteins involved in neuronal differentiation of neuroblastoma cell line N1E-115. Electrophoresis (2007) 0.79
Targeting epigenetic readers in cancer. N Engl J Med (2012) 0.79
Genetic factors in assisted reproduction. Wien Klin Wochenschr (2003) 0.78
Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations. J Cancer Res Clin Oncol (2013) 0.78
Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation. Asian J Androl (2012) 0.78
The cell cycle and tuberous sclerosis. Prog Cell Cycle Res (2003) 0.78
Blocking mTORC1 activity by rapamycin leads to impairment of spatial memory retrieval but not acquisition in C57BL/6J mice. Behav Brain Res (2012) 0.78
Tuberous sclerosis genes regulate cellular 14-3-3 protein levels. Biochem Biophys Res Commun (2003) 0.78
Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation. J Neuropathol Exp Neurol (2002) 0.77
Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells. Eur J Clin Invest (2015) 0.77
The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach. Int J Oncol (2005) 0.77
The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses. Int J Oncol (2005) 0.77
Phosphorylation of nuclear and cytoplasmic pools of ribosomal protein S6 during cell cycle progression. Amino Acids (2012) 0.77
Absence of microdeletions in the azoospermia-factor region of the Y-chromosome in Viennese men seeking assisted reproduction. Wien Klin Wochenschr (2003) 0.76
Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products. Biochem Biophys Res Commun (2003) 0.76
Amniotic fluid stem cells: future perspectives. Stem Cells Int (2012) 0.76
Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells. Hum Mol Genet (2012) 0.76